Cite
HARVARD Citation
Herishanu, Y. et al. (2021). Obinutuzumab in the treatment of autoimmune haemolytic anaemia and immune thrombocytopenia in patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma. British journal of haematology. pp. e1-e4. [Online].